People's United Financial’s Corcept Therapeutics CORT Stock Holding History

People's United Financial’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-91,003	Closed	-$1.28M	–	726
2018 Q3	$1.28M	Hold	91,003	–	–	0.04%	303
2018 Q2	$1.43M	Hold	91,003	–	–	0.04%	359
2018 Q1	$1.5M	Hold	91,003	–	–	0.05%	280
2017 Q4	$1.64M	Buy	+91,003	New	+$1.65M	0.05%	274

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

People's United Financial's CORT Position: Q4 2018 in Review

People's United Financial sold out of Corcept Therapeutics (CORT) in Q4 2018, closing a stake of 91,003 shares — an estimated $1.28M sold.

People's United Financial first reported a position in CORT in Q4 2017 and held it in 4 quarters. The position peaked at $1.64M in Q4 2017. 222 funds tracked by Wall St. Rank hold CORT as of Q4 2018.

People's United Financial reported no remaining Corcept Therapeutics position as of Q4 2018 after selling out during the quarter.
People's United Financial sold 91,003 Corcept Therapeutics shares in Q4 2018, an estimated $1.28M.
People's United Financial first reported a position in Corcept Therapeutics in Q4 2017 and held it in 4 quarters.
People's United Financial's Corcept Therapeutics position peaked at $1.64M in Q4 2017.
222 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2018.

Based on People's United Financial's 13F filing for Q4 2018, filed 14 Feb 2019.